Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism

Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence

(2018) Anna K. Jönsson et al.   CNS DRUGS

Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.

(2018) Magdalena Johansson et al.   THROMBOSIS RESEARCH

Identification of unique venous thromboembolism-susceptibility variants in African-Americans

(2017) Sebastian Armasu et al.   THROMBOSIS AND HAEMOSTASIS

Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims

(2017) Dale R. Burwen et al.   THROMBOSIS RESEARCH

Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case–control study

(2017) Alenka Premuš Marušič et al.   International Journal of Clinical Pharmacy

Genetic basis of ethnic disparities in VTE risk

(2016) N. S. Key et al.   BLOOD

Incidence and risk factors for venous thromboembolism following surgical treatment of fractures below the hip: a meta-analysis

(2016) Lei Tan et al.   International Wound Journal

Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer

(2016) Yuhui Zhang et al.   Scientific Reports

Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study

(2015) Valentino Conti et al.   BMC Psychiatry

Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism

(2015) Wei-Sheng Chung et al.   THROMBOSIS AND HAEMOSTASIS

Diabetes is associated with increased risk of venous thromboembolism: A systematic review and meta-analysis

(2015) Jing Bai et al.   THROMBOSIS RESEARCH

Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case–control study

(2015) Aneel A. Ashrani et al.   THROMBOSIS RESEARCH

Association Between the Metabolic Syndrome, Its Individual Components, and Unprovoked Venous Thromboembolism

(2014) Walter Ageno et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Corrado Barbui et al.   DRUG SAFETY

African–Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation

(2012) Lara N. Roberts et al.   BLOOD COAGULATION & FIBRINOLYSIS

Risk of venous thromboembolism during treatment with antipsychotic agents

(2012) Jiří Masopust et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Association between cardiovascular disease risk factors and occurrence of venous thromboembolism

(2012) Pamela L. Lutsey et al.   THROMBOSIS AND HAEMOSTASIS

The Metabolic Syndrome and Its Individual Components: Its Association with Venous Thromboembolism in a Mediterranean Population

(2011) Amparo Vayá et al.   Metabolic Syndrome and Related Disorders

Risk Factors for Venous Thromboembolism

(2010) Anders G. Holst et al.   CIRCULATION

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients

(2010) Bart C. Kleijer et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metabolic Syndrome Is Associated With Venous Thromboembolism in the Korean Population

(2009) Moon Ju Jang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY